# Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study

> **NCT01801670** · — · WITHDRAWN · sponsor: **Boston University**

## Conditions studied

- Pruritus

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Blood

## Key facts

- **NCT ID:** NCT01801670
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Enrollment was too slow, so no participants were ever enrolled.
- **Last updated:** 2015-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01801670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01801670, "Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01801670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*